.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Renal cell carcinoma (RCC) represents a significant global health challenge, often requiring advanced systemic therapies. While tyrosine kinase inhibitors have improved outcomes, sunitinib resistance in RCC remains a formidable barrier to long-term survival. Researchers are now investigating the role of ferroptosis—a form of regulated cell death—as a potential solution to this therapeutic hurdle. A recent study identifies PR domain-containing protein 1 (PRDM1) as a critical regulator in this process.
PRDM1 is a zinc finger protein known to regulate tumor progression in various malignancies. However, its specific role in kidney cancer was previously unclear. In this study, bioinformatics analysis and laboratory experiments revealed that PRDM1 expression is significantly elevated in RCC tissues compared to healthy cells. Interestingly, silencing this protein induced ferroptosis and successfully enhanced the sensitivity of cancer cells to treatment. Therefore, targeting PRDM1 may provide a pathway to overcome sunitinib resistance in RCC.
The study further explored the underlying molecular pathways to explain these effects. Results demonstrated that PRDM1 directly binds to the promoter of ESM1, stimulating its transcription. When researchers knocked down PRDM1, ESM1 levels dropped, which subsequently suppressed the PI3K/Akt signaling pathway. Because this pathway often promotes cell survival, its inhibition facilitates ferroptosis. Furthermore, animal xenograft models confirmed that reducing PRDM1 levels leads to significant anti-tumor activity in vivo.
These findings offer a fresh perspective on managing advanced kidney cancer. By modulating the PRDM1/ESM1/PI3K/Akt axis, clinicians might eventually improve the efficacy of standard chemotherapies. Consequently, this research paves the way for novel combination therapies that target epigenetic regulators to sensitize resistant tumors.
High levels of PRDM1 appear to contribute to sunitinib resistance. Knocking down this protein reduces ESM1 expression and inhibits PI3K/Akt signaling, which helps trigger ferroptosis in resistant cells.
Ferroptosis is an iron-dependent form of regulated cell death characterized by lipid peroxidation. It is distinct from apoptosis and is becoming a major area of focus for treating drug-resistant cancers.
Future studies will likely focus on developing pharmacological inhibitors of PRDM1 or ESM1 to be used in combination with sunitinib to improve patient outcomes in clinical settings.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Refer to the latest local and national guidelines for clinical practice.
References
Zhang YS et al. PRDM1 Knockdown Promotes Ferroptosis and Sunitinib Sensitivity by Modulating the PI3K/Akt Signaling Through Inhibition of ESM1 Transcription in Renal Cell Carcinoma. Kaohsiung J Med Sci. 2026 Feb 16. doi: 10.1002/kjm2.70187. PMID: 41693648.
Bukavina L, et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol. 2022;82(5):529-542.
Xie Y, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369-379.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Recent research highlights PRDM1 knockdown as a potential mechanism to overcome sunitinib resistance in renal cell carcinoma by inducing ferroptosis....
6 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
